Related Experiment Videos
[Glycopeptides].
1Département d'anesthésie et de réanimation, hôpital Nord, Marseille, France.
Annales Francaises D'Anesthesie Et De Reanimation
|April 27, 2000
Summary
Glycopeptides are crucial antibiotics for treating Gram-positive infections in intensive care units. Responsible antibiotic stewardship is essential to combat emerging resistance and ensure effective patient outcomes.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Therapeutic applications
Background:
- Glycopeptides are bactericidal antibiotics targeting Gram-positive bacteria by inhibiting peptidoglycan synthesis.
- Clinical use exceeds 30 years with minimal resistance until recent emergence in enterococci and Staphylococcus aureus.
- Rising resistance poses a significant therapeutic challenge, potentially leading to treatment failure.
Purpose of the Study:
- To review the pharmacology, pharmacokinetics, and therapeutic applications of glycopeptides.
- To highlight the growing concern of antimicrobial resistance to glycopeptides.
- To emphasize the importance of judicious antibiotic use in intensive care settings.
Main Methods:
- Systematic review of French and English articles from the Medline database.
- Inclusion of major review articles for comprehensive data.
- Selection based on article quality, originality, and recent data.
Main Results:
- Glycopeptides exhibit narrow-spectrum activity against Gram-positive organisms.
- Emerging resistance mechanisms in enterococci and Staphylococcus aureus are complex.
- Resistance threatens effective treatment, necessitating careful antibiotic management.
Conclusions:
- Glycopeptides remain fundamental for treating infections in intensive care units.
- Intensive care unit staff bear responsibility for the appropriate use of these vital antibiotics.
- Adherence to prescription guidelines is critical to preserve glycopeptide efficacy.